Anti-PAPP1/ PAPPA/ ASBABP2 functional antibody

Anti-PAPP1/ PAPPA/ ASBABP2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PAPPA/PAPPA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1169-Ab-1/ GM-Tg-hg-SE1169-Ab-2Anti-Human PAPPA monoclonal antibodyHuman
GM-Tg-rg-SE1169-Ab-1/ GM-Tg-rg-SE1169-Ab-2Anti-Rat PAPPA monoclonal antibodyRat
GM-Tg-mg-SE1169-Ab-1/ GM-Tg-mg-SE1169-Ab-2Anti-Mouse PAPPA monoclonal antibodyMouse
GM-Tg-cynog-SE1169-Ab-1/ GM-Tg-cynog-SE1169-Ab-2Anti-Cynomolgus/ Rhesus macaque PAPPA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1169-Ab-1/ GM-Tg-felg-SE1169-Ab-2Anti-Feline PAPPA monoclonal antibodyFeline
GM-Tg-cang-SE1169-Ab-1/ GM-Tg-cang-SE1169-Ab-2Anti-Canine PAPPA monoclonal antibodyCanine
GM-Tg-bovg-SE1169-Ab-1/ GM-Tg-bovg-SE1169-Ab-2Anti-Bovine PAPPA monoclonal antibodyBovine
GM-Tg-equg-SE1169-Ab-1/ GM-Tg-equg-SE1169-Ab-2Anti-Equine PAPPA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1169-Ab-1/ GM-Tg-hg-SE1169-Ab-2; GM-Tg-rg-SE1169-Ab-1/ GM-Tg-rg-SE1169-Ab-2;
GM-Tg-mg-SE1169-Ab-1/ GM-Tg-mg-SE1169-Ab-2; GM-Tg-cynog-SE1169-Ab-1/ GM-Tg-cynog-SE1169-Ab-2;
GM-Tg-felg-SE1169-Ab-1/ GM-Tg-felg-SE1169-Ab-2; GM-Tg-cang-SE1169-Ab-1/ GM-Tg-cang-SE1169-Ab-2;
GM-Tg-bovg-SE1169-Ab-1/ GM-Tg-bovg-SE1169-Ab-2; GM-Tg-equg-SE1169-Ab-1/ GM-Tg-equg-SE1169-Ab-2
Products NameAnti-PAPPA monoclonal antibody
Formatmab
Target NamePAPPA
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PAPPA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1169-Ag-1Recombinant multi-species PAPP1/ PAPPA/ ASBABP2 protein


    Target information

    Target IDGM-SE1169
    Target NamePAPPA
    Gene ID5069,18491,313262,706783,481692,101089154,282647,100033920
    Gene Symbol and Synonyms8430414N03Rik,ASBABP2,DIPLA1,IGFBP-4ase,PAG1,PAPA,PAPP-A,PAPPA,PAPPA1
    Uniprot AccessionQ13219
    Uniprot Entry NamePAPP1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000182752
    Target ClassificationTumor-associated antigen (TAA)

    The target: PAPPA, gene name: PAPPA, also named as ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A1, PAPPA. This gene encodes a secreted metalloproteinase which cleaves insulin-like growth factor binding proteins (IGFBPs). Following IGFBP cleavage, insulin growth factors dissociate from IGFBPs and bind to IGF receptors, resulting in activation of the IGF pathway. The encoded protein plays a role in bone formation, inflammation, wound healing and female fertility. Enhanced expression of this protein is associated with diabetic nephropathy in human patients and this protein may promote tumor invasion and growth in various human cancers. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.